M
MapLight Therapeutics Inc
NASDAQ:MPLT
MapLight Therapeutics Inc
NASDAQ:MPLT
Price:
28.51
USD
5.99%
Market Closed
Market Cap:
$1.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MapLight Therapeutics Inc
NASDAQ:MPLT
|
US |
|
CNB Financial Corp
NASDAQ:CCNE
|
US |
|
Maisons du Monde SA
PAR:MDM
|
FR |
|
Blue Biofuels Inc
OTC:BIOF
|
US |
|
P
|
Perpetual Energy Inc
TSX:PMT
|
CA |
|
First Niles Financial Inc
OTC:FNFI
|
US |
|
Gryphon Digital Mining Inc
NASDAQ:ABTC
|
US |
|
China Aviation Oil (Singapore) Corporation Ltd
SGX:G92
|
SG |
|
C
|
Cosmos Holdings Inc
NASDAQ:COSM
|
US |
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
UK |
|
Accelerated Technologies Holding Corp
OTC:ATHC
|
US |
|
Rosseti Severo-Zapad PAO
MOEX:MRKZ
|
RU |
|
N
|
Northview Acquisition Corp
NASDAQ:NVAC
|
US |
|
First Hotel Co Ltd
TWSE:2706
|
TW |
|
Harford Bank
OTC:HFBK
|
US |
|
O
|
Ottakringer Getraenke AG
VSE:OTV
|
AT |
|
I
|
Incannex Healthcare Ltd
NASDAQ:IXHL
|
AU |
|
Nusco SpA
MIL:NUS
|
IT |
|
Cavendish Financial PLC
LSE:CAV
|
UK |
|
Mirle Automation Corp
TWSE:2464
|
TW |
|
I
|
Intops Co Ltd
KOSDAQ:049070
|
KR |
|
Zignago Vetro SpA
MIL:ZV
|
IT |
|
C
|
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
|
TW |
Cash Flow Statement
Cash Flow Statement
MapLight Therapeutics Inc
MapLight Therapeutics Inc
Currency:
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(30)
|
(56)
|
(78)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
|
| Other Non-Cash Items |
3
|
(1)
|
(0)
|
|
| Change in Working Capital |
(0)
|
5
|
(1)
|
|
| Cash from Operating Activities |
(27)
N/A
|
(52)
-96%
|
(79)
-52%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(1)
|
(0)
|
(1)
|
|
| Other Items |
0
|
0
|
(80)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+38%
|
(81)
-17 387%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
33
|
105
|
120
|
|
| Other |
0
|
0
|
(2)
|
|
| Cash from Financing Activities |
33
N/A
|
105
+215%
|
118
+13%
|
|
| Change in Cash | ||||
| Net Change in Cash |
6
N/A
|
52
+790%
|
(42)
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(27)
N/A
|
(52)
-92%
|
(80)
-52%
|
|
Switch to:
Switch to:
See Also
Discover More
